伊朗医疗市场的价格透明度

IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES
Ameneh Rahban , Abolfazl Ghahramani , Hasan Yusefzadeh , Iraj Harirchi , Cyrus Alinia
{"title":"伊朗医疗市场的价格透明度","authors":"Ameneh Rahban ,&nbsp;Abolfazl Ghahramani ,&nbsp;Hasan Yusefzadeh ,&nbsp;Iraj Harirchi ,&nbsp;Cyrus Alinia","doi":"10.1016/j.hpopen.2024.100120","DOIUrl":null,"url":null,"abstract":"<div><p>Insufficient price transparency has emerged as a pivotal contributor to patient dissatisfaction, escalating costs, and diminished productivity within Iran's health system. This study aims to delineate and elucidate a definition of price transparency, identify suitable strategies, and present the outcomes associated with establishing a health system that embraces transparent pricing while also addressing the challenges ahead. Employing a quantitative–qualitative research design, data were extracted from a semi-structured interviews with stakeholders. A purposive sampling method, encompassing sequential and snowball techniques, was employed to capture the perspectives of all stakeholders involved in the issue of price transparency in Iran. The interview data were analyzed using the grounded theory approach was classified into three categories: price transparency before, during, and after the receipt of healthcare services. Our findings reveal the causes of low price transparency, strategies to address the issue, and the consequences associated with increased levels of transparency. Ultimately, we contend that health systems can significantly enhance efficiency, patient satisfaction, and the performance of health insurance by adopting transparent pricing for health services, thus obviating the need for resource-intensive restructuring efforts.</p></div>","PeriodicalId":34527,"journal":{"name":"Health Policy Open","volume":"6 ","pages":"Article 100120"},"PeriodicalIF":1.7000,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590229624000054/pdfft?md5=2c07cab57db34a579c0b9b35541eacb1&pid=1-s2.0-S2590229624000054-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Price transparency in Iranian healthcare market\",\"authors\":\"Ameneh Rahban ,&nbsp;Abolfazl Ghahramani ,&nbsp;Hasan Yusefzadeh ,&nbsp;Iraj Harirchi ,&nbsp;Cyrus Alinia\",\"doi\":\"10.1016/j.hpopen.2024.100120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Insufficient price transparency has emerged as a pivotal contributor to patient dissatisfaction, escalating costs, and diminished productivity within Iran's health system. This study aims to delineate and elucidate a definition of price transparency, identify suitable strategies, and present the outcomes associated with establishing a health system that embraces transparent pricing while also addressing the challenges ahead. Employing a quantitative–qualitative research design, data were extracted from a semi-structured interviews with stakeholders. A purposive sampling method, encompassing sequential and snowball techniques, was employed to capture the perspectives of all stakeholders involved in the issue of price transparency in Iran. The interview data were analyzed using the grounded theory approach was classified into three categories: price transparency before, during, and after the receipt of healthcare services. Our findings reveal the causes of low price transparency, strategies to address the issue, and the consequences associated with increased levels of transparency. Ultimately, we contend that health systems can significantly enhance efficiency, patient satisfaction, and the performance of health insurance by adopting transparent pricing for health services, thus obviating the need for resource-intensive restructuring efforts.</p></div>\",\"PeriodicalId\":34527,\"journal\":{\"name\":\"Health Policy Open\",\"volume\":\"6 \",\"pages\":\"Article 100120\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-04-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590229624000054/pdfft?md5=2c07cab57db34a579c0b9b35541eacb1&pid=1-s2.0-S2590229624000054-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Policy Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590229624000054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590229624000054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

价格透明度不足已成为伊朗医疗系统中导致患者不满、成本上升和生产力下降的一个关键因素。本研究旨在界定和阐明价格透明度的定义,确定合适的策略,并介绍与建立价格透明的医疗系统相关的成果,同时应对未来的挑战。采用定量-定性研究设计,从与利益相关者的半结构化访谈中提取数据。采用了包括顺序和滚雪球技术在内的有目的抽样方法,以获取与伊朗价格透明问题有关的所有利益相关者的观点。采用基础理论方法对访谈数据进行了分析,并将其分为三类:接受医疗服务之前、期间和之后的价格透明度。我们的研究结果揭示了价格透明度低的原因、解决这一问题的策略以及与透明度提高相关的后果。最终,我们认为,医疗系统可以通过采用透明的医疗服务定价来显著提高效率、患者满意度和医疗保险的绩效,从而避免了资源密集型的重组工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Price transparency in Iranian healthcare market

Insufficient price transparency has emerged as a pivotal contributor to patient dissatisfaction, escalating costs, and diminished productivity within Iran's health system. This study aims to delineate and elucidate a definition of price transparency, identify suitable strategies, and present the outcomes associated with establishing a health system that embraces transparent pricing while also addressing the challenges ahead. Employing a quantitative–qualitative research design, data were extracted from a semi-structured interviews with stakeholders. A purposive sampling method, encompassing sequential and snowball techniques, was employed to capture the perspectives of all stakeholders involved in the issue of price transparency in Iran. The interview data were analyzed using the grounded theory approach was classified into three categories: price transparency before, during, and after the receipt of healthcare services. Our findings reveal the causes of low price transparency, strategies to address the issue, and the consequences associated with increased levels of transparency. Ultimately, we contend that health systems can significantly enhance efficiency, patient satisfaction, and the performance of health insurance by adopting transparent pricing for health services, thus obviating the need for resource-intensive restructuring efforts.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Policy Open
Health Policy Open Medicine-Health Policy
CiteScore
3.80
自引率
0.00%
发文量
21
审稿时长
40 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信